Issue Date | Title | Author(s) |
2020-03-13 | A liquid biopsy to detect multidrug resistance and disease burden in multiple myeloma. | Rajeev Krishnan, S; De Rubis, G; Suen, H; Joshua, D; Lam Kwan, Y; Bebawy, M |
2019-10-01 | Activated and Bone-marrow Resident Treg Alterations Underlie Malignant Transformation from MGUS to Multiple Myeloma | Vuckovic, S; Bryant, C; Marsh-Wakefield, F; Kruzins, A; McGuire, H; Yang, S; de St Groth, BF; Nassif, N; Byrne, SN; Gibson, J; Brown, C; Larsen, S; McCulloch, D; Boyle, R; Clark, G; Joshua, D; Ho, PJ |
2012-09-06 | CD86<sup>+</sup>or HLA-G<sup>+</sup> can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis | Brown, R; Kabani, K; Favaloro, J; Yang, S; Ho, PJ; Gibson, J; Fromm, P; Suen, H; Woodland, N; Nassif, N; Hart, D; Joshua, D |
2010 | Characterisation And Relevance Of Cd138-Negative Plasma Cells In Plasma Cell Myeloma | Reid, S; Yang, S; Brown, R; Kabani, K; Aklilu, E; Ho, P; Woodland, N; Joshua, D |
2015-09 | Digital PCR for MRD detection of myeloma | McAuliffe, S; Joshua, D; Brown, R; Catalano, A; Ho, PJ; Nassif, N; Woodland, N; Hart, D; Weatherburn, C; Yang, S; Suen, H; Paul, C; Gibson, J |
2020-10 | Inverse relationship between oligoclonal expanded CD69- TTE and CD69+ TTE cells in bone marrow of multiple myeloma patients. | Vuckovic, S; Bryant, CE; Lau, KHA; Yang, S; Favaloro, J; McGuire, HM; Clark, G; de St Groth, BF; Marsh-Wakefield, F; Nassif, N; Abadir, E; Vanguru, V; McCulloch, D; Brown, C; Larsen, S; Dunkley, S; Khoo, L; Gibson, J; Boyle, R; Joshua, D; Ho, PJ |
2013 | Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance | Bryant, C; Suen, H; Brown, R; Yang, S; Favaloro, J; Aklilu, E; Gibson, J; Ho, P; Iland, H; Fromm, P; Woodland, N; Nassif, N; Hart, D; Joshua, D |
2019-01-01 | Mass cytometry discovers two discrete subsets of CD39<sup>−</sup> treg which discriminate MGUS from multiple myeloma | Marsh-Wakefield, F; Kruzins, A; McGuire, HM; Yang, S; Bryant, C; Barbara, BF; Nassif, N; Byrne, SN; Gibson, J; Brown, C; Larsen, S; McCulloch, D; Boyle, R; Clark, G; Joshua, D; Ho, PJ; Vuckovic, S |
2016-08-01 | Multiple myeloma causes clonal T-cell immunosenescence: Identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade | Suen, H; Brown, R; Yang, S; Weatherburn, C; Ho, PJ; Woodland, N; Nassif, N; Barbaro, P; Bryant, C; Hart, D; Gibson, J; Joshua, D |
2014-01-01 | Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma | Favaloro, J; Liyadipitiya, T; Brown, R; Yang, S; Suen, H; Woodland, N; Nassif, N; Hart, D; Fromm, P; Weatherburn, C; Gibson, J; Ho, PJ; Joshua, D |
2022-08 | OAB-023: Single-cell analysis reveals disease induced perturbations of CD8+T-cell subsets in the bone marrow and peripheral blood of newly diagnosed multiple myeloma patients | Favaloro, J; Bryant, C; Abadir, E; Yang, S; Gardiner, S; Nassif, N; Sedger, L; Joshua, D; Ho, PJ |
2015-09-02 | Using digital polymerase chain reaction to detect minimal residual disease in myeloma by identifying FGFR3 up-regulation | McAuliffe, S; Brown, R; Catalano, A; Ho, PJ; Nassif, N; Woodland, N; Hart, D; Weatherburn, C; Yang, S; Suen, H; Paul, C; Joshua, D; Gibson, J |